As discussed earlier, Koeth et al.'s study on gut microbiota-induced TMAO in stable patients undergoing cardiac evaluation showed significant dose-dependent associations between plasma L-carnitine levels and risks of coronary artery disease, peripheral artery disease, and overall CVD after correction for common CVD risk factors [18]
To view a copy of this licence, visit About this article Cite this article GokulRaj, D., Lakshmanan, M.K., Sridharan, Y
[DOI] [PMC free article] [PubMed] [Google Scholar] 100.Elliott J.A., Docherty N.G., Haag J., Eckhardt H.G., Ravi N., Reynolds J.V., Le Roux C.W
Phase III - further modification and excretion [edit] After phase II reactions, the xenobiotic conjugates may be further metabolised
, Terashima, H